Evidence map›Paper›PMID 39925965›Full record

ArticleRegenerative therapy2025

Applicability of the regression approach for histological multi-class grading in clear cell renal cell carcinoma.

Mayu Shibata, Akihiro Umezawa, Saki Aoto, Kohji Okamura, Michiyo Nasu, Ryuichi Mizuno, Mototsugu Oya, Kei Yura, Shuji Mikami

Abstract read
In one paragraph

Article in Regenerative therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mayu ShibataCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Akihiro UmezawaCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Saki AotoMedical Genome Center, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Kohji OkamuraDepartment of Systems BioMedicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Michiyo NasuCenter for Regenerative Medicine, National Center for Child Health and Development Research Institute, Tokyo, Japan.
Ryuichi MizunoDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Mototsugu OyaDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Kei YuraDepartment of Transdisciplinary Engineering, Ochanomizu University, Tokyo, Japan.
Shuji MikamiDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The histological grading of carcinoma has been one of the central applications of task-specific deep learning in pathology. The deep learning method has pushed away the regression approach, which has been exploited for two-class classification, to address multi-class classification. However, the applicability of the regression approach on multi-class carcinoma grading has not been extensively investigated. Here, we show that the regression approach is sufficiently compatible with classification regarding the four-class grading of clear cell renal cell carcinoma using 11,826 histological image patches from 16 whole slide images. Using convolutional neural network models (DenseNet-121 and Inception-v3), we found that regression models predict as accurately as classification models, achieving an accuracy of 0.990 at the highest, with fewer prediction errors by two or more grades. Furthermore, we found that the predictions by the regression models qualitatively capture intra-tumor heterogeneity of grades using the composite image patches. Our results demonstrate that the regression approach offers advantages in making a core of the multi-class grade prediction tools for practice.

Indexed as

Carcinoma gradingClassification modelsConvolutional neural networks (CNN)Intra-tumor heterogeneity (ITH)Regression models

Identifiers

PMID39925965
PMCPMC11802374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.